116544 ⎘
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2); Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1) Alpha-N-acetylglucosaminidase (3.2.1.50)
TARGETED THERAPEUTIC LYSOSOMAL ENZYME FUSION PROTEINS AND USES THEREOF
#2CNS DELIVERY OF THERAPEUTIC AGENTS
#3METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE A
#4METHODS FOR TREATING INHERITED METABOLIC DISORDERS
#5COMPOSITIONS AND METHODS OF USING TWO-PROMOTER VECTOR FOR TREATMENT OF LYSOSOMAL STORAGE DISORDERS
#6METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
#7METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#8CLEANING COMPOSITIONS CONTAINING DISPERSINS II
#9COMPOSITIONS AND METHODS FOR INCREASING TRANSPORT INTO THE BRAIN
#10Mutant of alpha-N-Acetylglucosaminidase
#11DISEASE CORRECTION BY DELIVERY OF AAV8 VECTORS EXPRESSING CODON OPTIMIZED NAGLU
#12CNS DELIVERY OF THERAPEUTIC AGENTS
#13AAV-NAGLU VECTORS FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS IIIB
#14Methods and compositions for CNS delivery of iduronate-2-sulfatase
#15TREATMENT OF SANFILIPPO SYNDROME TYPE B
#16Methods and compositions for CNS delivery of heparan N-sulfatase
#17METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#18Targeted Therapeutic Lysosomal Enzyme Fusion Proteins and Uses Thereof
#19Cleaning compositions comprising dispersin variants
#20DELIVERING ENZYME USING AN INJECTABLE HYDROGEL DEPOT
#21METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACTIVITY IN THE CNS
#22Methods and compositions for CNS delivery of arylsulfatase A
#23MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES
#24Cleaning compositions containing Dispersins III
#25CNS delivery of therapeutic agents
#26Methods and compositions for CNS delivery of iduronate-2-sulfatase
#27Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#28SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER
#29Methods and compositions for CNS delivery of heparan n-sulfatase
#30Delivering enzyme using an injectable hydrogel depot
#31ENZYME REPLACEMENT THERAPY IN MUCOPOLYSACCHARIDOSIS IIIB PATIENTS
#32Crystal structure of Autolysin E, method of producing the crystal and its use in screening methods
#33N-acetyl-alpha-D-glucosaminidase deficiency compositions and methods
#34Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety
#35Methods and compositions for CNS delivery of arylsulfatase A
#36LYSOSOMAL TARGETING AND USES THEREOF
#37Nucleic acids encoding targeted therapeutic lysosomal enzyme fusion proteins
#38Lysosomal targeting of enzymes, and uses thereof
#39GENERATION OF MANNOSE-6-PHOSPHATE CONTAINING RECOMBINANT ALPHA-N-ACETYL GLUCOSAMINIDASE
#40Lysosomal targeting and uses thereof
#41Mannose-6-phosphate bearing peptides fused to lysosomal enzymes
#42Methods of treating Mucopolysaccharidosis IIIB (MPSIIIB)
#43RECOMBINANT HUMAN NAGLU PROTEIN AND USES THEREOF
#44Delivery of therapeutic compounds to the brain and other tissues
#45Adenoassociated virus vectors for the treatment of lysosomal storage disorders
#46CNS delivery of therapeutic agents
#47Methods and compositions for increasing N-acetylglucosaminidase (NAGLU) activity in the CNS using a fusion antibody comprising an anti-human insulin receptor antibody and NAGLU
#48Peptide linkers for polypeptide compositions and methods for using same
#49Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#50Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#51Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#52Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#53SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER
#54Delivery of therapeutic compounds to the brain and other tissues
#55Crystal structure of human α-N-acetylglucosaminidase
#56Methods and compositions for CNS delivery of iduronate-2-sulfatase
#57Peptide linkers for polypeptide compositions and methods for using same
#58Intranasal delivery of AAV encoding therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
#59Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
#60Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase
#61Recombinant human NaGlu protein and uses thereof
#62Method for Producing Recombinant Glycoproteins Having Beta1,2-Bound Xylose Residues
#63Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases
#64Peptide linkers for polypeptide compositions and methods for using same
#65Delivery of therapeutic compounds to the brain and other tissues
#66Crystal structure of human alpha-N-acetylglucosaminidase
#67Methods and compositions for CNS delivery of heparan N-sulfatase
#68CNS delivery of therapeutic agents
#69Delivery of therapeutic compounds to the brain and other tissues
#70Synthetic mammalian α-N-acetylglucosaminidase and genetic sequences encoding same
#71BETA 1,2-xylosyltransferase-gene from arabidopsis
#72Delivery of therapeutic compounds to the brain and other tissues